APDN vs. ASPS, PFMT, NVEE, DFIN, ULS, NEO, GWAV, AREB, LGMK, and SMIT
Should you be buying Applied DNA Sciences stock or one of its competitors? The main competitors of Applied DNA Sciences include Altisource Portfolio Solutions (ASPS), Performant Financial (PFMT), NV5 Global (NVEE), Donnelley Financial Solutions (DFIN), UL Solutions (ULS), NeoGenomics (NEO), Greenwave Technology Solutions (GWAV), American Rebel (AREB), LogicMark (LGMK), and Schmitt Industries (SMIT).
Applied DNA Sciences (NASDAQ:APDN) and Altisource Portfolio Solutions (NASDAQ:ASPS) are both small-cap industrial products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation, dividends, media sentiment and community ranking.
22.2% of Applied DNA Sciences shares are owned by institutional investors. Comparatively, 41.4% of Altisource Portfolio Solutions shares are owned by institutional investors. 10.3% of Applied DNA Sciences shares are owned by company insiders. Comparatively, 5.7% of Altisource Portfolio Solutions shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Applied DNA Sciences received 67 more outperform votes than Altisource Portfolio Solutions when rated by MarketBeat users. However, 59.06% of users gave Altisource Portfolio Solutions an outperform vote while only 58.99% of users gave Applied DNA Sciences an outperform vote.
Applied DNA Sciences has a beta of 0.26, indicating that its stock price is 74% less volatile than the S&P 500. Comparatively, Altisource Portfolio Solutions has a beta of 1.01, indicating that its stock price is 1% more volatile than the S&P 500.
Altisource Portfolio Solutions has a net margin of -36.22% compared to Applied DNA Sciences' net margin of -222.33%. Altisource Portfolio Solutions' return on equity of 0.00% beat Applied DNA Sciences' return on equity.
In the previous week, Applied DNA Sciences had 4 more articles in the media than Altisource Portfolio Solutions. MarketBeat recorded 7 mentions for Applied DNA Sciences and 3 mentions for Altisource Portfolio Solutions. Altisource Portfolio Solutions' average media sentiment score of 1.59 beat Applied DNA Sciences' score of 0.56 indicating that Altisource Portfolio Solutions is being referred to more favorably in the news media.
Applied DNA Sciences currently has a consensus price target of $7.00, suggesting a potential upside of 1,057.02%. Given Applied DNA Sciences' higher probable upside, research analysts clearly believe Applied DNA Sciences is more favorable than Altisource Portfolio Solutions.
Applied DNA Sciences has higher earnings, but lower revenue than Altisource Portfolio Solutions. Altisource Portfolio Solutions is trading at a lower price-to-earnings ratio than Applied DNA Sciences, indicating that it is currently the more affordable of the two stocks.
Summary
Altisource Portfolio Solutions beats Applied DNA Sciences on 10 of the 17 factors compared between the two stocks.
Get Applied DNA Sciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for APDN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding APDN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Applied DNA Sciences Competitors List
Related Companies and Tools
